Norman Sussman - 10 Dec 2021 Form 4 Insider Report for DURECT CORP (DRRX)

Role
Chief Medical Officer
Signature
/s/ Norman Sussman
Issuer symbol
DRRX
Transactions as of
10 Dec 2021
Net transactions value
-$9,495
Form type
4
Filing time
11 Sep 2024, 12:53:49 UTC
Next filing
10 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRRX Common Stock Sale $9,495 -9,000 -100% $1.06 0 10 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed late due to an inadvertent administrative error. The sale reported herein was executed by the account manager for the benefit of the Reporting Person's managed account, without any instruction from or knowledge of the Reporting Person.
F2 The number of shares and price are pre-the company's 10:1 reverse stock split and the numbers do not reflect the stock split.